| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2770 |
| Trial ID | NCT05020015 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | TAK-007 |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) |
| Year | 2021 |
| Country | United States |
| Company sponsor | Takeda |
| Other ID(s) | TAK-007-2001|2021-002086-18 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||